共 374 条
[1]
Banach M(2017)Chemotherapy-induced neuropathies-a growing problem for patients and health care providers Brain Behav 7 e00558-905
[2]
Juranek JK(2016)The evolving and future role of taxanes in squamous cell carcinomas of the head and neck: a review JAMA Otolaryngol Head Neck Surg 142 898-v8
[3]
Zygulska AL(2007)Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents Ann Oncol 18 v3-183
[4]
Mody MD(2017)Pathophysiology of chemotherapy-induced peripheral neuropathy Front Mol Neurosci 10 174-494
[5]
Gill HS(2016)Chemotherapy-induced peripheral neuropathy: current status and progress Gynecol Oncol 140 176-3146
[6]
Saba NF(1995)Paclitaxel-induced neuropathy Ann Oncol 6 489-749
[7]
Fojo T(2019)Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-κB Front Pharmacol 10 365-707
[8]
Menefee M(2020)Taxane-induced neurotoxicity: pathophysiology and therapeutic perspectives Br J Pharmacol 177 3127-497
[9]
Starobova H(2017)Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review Br J Anaesth 119 737-97.e5
[10]
Vetter I(2014)Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain Nat Rev Neurol 10 694-5656